In HepG2 cells, coexisting carnitine deficiency masks important indicators of marginal biotin deficiency.

BACKGROUND A large number of birth defects are related to nutrient deficiencies; concern that biotin deficiency is teratogenic in humans is reasonable. Surprisingly, studies indicate that increased urinary 3-hydroxyisovalerylcarnitine (3HIAc), a previously validated marker of biotin deficiency, is not a valid biomarker in pregnancy. OBJECTIVE In this study we hypothesized that coexisting carnitine deficiency can prevent the increase in 3HIAc due to biotin deficiency. METHODS We used a 2-factor nutrient depletion design to induce isolated and combined biotin and carnitine deficiency in HepG2 cells and then repleted cells with carnitine. To elucidate the metabolic pathogenesis, we quantitated intracellular and extracellular free carnitine, acylcarnitines, and acylcarnitine ratios using liquid chromatography-tandem mass spectrometry. RESULTS Relative to biotin-sufficient, carnitine-sufficient cells, intracellular acetylcarnitine increased by 90%, propionylcarnitine more than doubled, and 3HIAc increased by >10-fold in biotin-deficient, carnitine-sufficient (BDCS) cells, consistent with a defensive mechanism in which biotin-deficient cells transesterify the acyl-coenzyme A (acyl-CoA) substrates of the biotin-dependent carboxylases to the related acylcarnitines. Likewise, in BDCS cells, the ratio of acetylcarnitine to malonylcarnitine and the ratio of propionylcarnitine to methylmalonylcarnitine both more than tripled, and the ratio of 3HIAc to 3-methylglutarylcarnitine (MGc) increased by >10-fold. In biotin-deficient, carnitine-deficient (BDCD) cells, the 3 substrate-derived acylcarnitines changed little, but the substrate:product ratios were masked to a lesser extent. Moreover, carnitine repletion unmasked biotin deficiency in BDCD cells as shown by increases in acetylcarnitine, propionylcarnitine, and 3HIAc (each increased by >50-fold). Likewise, ratios of acetylcarnitine:malonylcarnitine, propionylcarnitine:methylmalonylcarnitine, and 3HIAc:MGc all increased by >8-fold. CONCLUSIONS Our findings provide strong evidence that coexisting carnitine deficiency masks some indicators of biotin deficiency and support the potential importance of the ratios of acylcarnitines arising from the acyl-CoA substrates and products for biotin-dependent carboxylases in detecting the biotin deficiency that is masked by coexisting carnitine deficiency.

[1]  M. Caudill,et al.  Pregnancy and lactation alter biomarkers of biotin metabolism in women consuming a controlled diet. , 2014, The Journal of nutrition.

[2]  D. Mock,et al.  Measurement of acylcarnitine substrate to product ratios specific to biotin-dependent carboxylases offers a combination of indicators of biotin status in humans. , 2012, The Journal of nutrition.

[3]  D. Mock,et al.  Urinary excretion of 3-hydroxyisovaleric acid and 3-hydroxyisovaleryl carnitine increases in response to a leucine challenge in marginally biotin-deficient humans. , 2011, The Journal of nutrition.

[4]  G. Miller,et al.  Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  D. Mock,et al.  Urinary excretion of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans. , 2011, The Journal of nutrition.

[6]  J. Zempleni,et al.  Biotin requirements are lower in human Jurkat lymphoid cells but homeostatic mechanisms are similar to those of HepG2 liver cells. , 2010, The Journal of nutrition.

[7]  D. Mock,et al.  Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans. , 2010, Analytical chemistry.

[8]  R. Ringseis,et al.  Low availability of carnitine precursors as a possible reason for the diminished plasma carnitine concentrations in pregnant women , 2010, BMC pregnancy and childbirth.

[9]  A. Arduini,et al.  Carnitine, mitochondrial function and therapy. , 2009, Advanced drug delivery reviews.

[10]  K. Eder,et al.  Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentration , 2009, European Journal of Clinical Nutrition.

[11]  W. R. Wikoff,et al.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites , 2009, Proceedings of the National Academy of Sciences.

[12]  D. Mock Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in mice. , 2009, The Journal of nutrition.

[13]  H. Arafa Carnitine deficiency: a possible risk factor in paracetamol hepatotoxicity , 2009, Archives of Toxicology.

[14]  B. Koletzko,et al.  Determination of Carnitine Ester Patterns During the Second Half of Pregnancy, at Delivery, and in Neonatal Cord Blood by Tandem Mass Spectrometry: Complex and Dynamic Involvement of Carnitine in the Intermediary Metabolism , 2007, Pediatric Research.

[15]  Salim S. Al-Rejaie,et al.  Propionyl‐L‐carnitine prevents The Progression of Cisplatin‐Induced Cardiomyopathy in a Carnitine‐Depleted Rat Model , 2006, Pharmacological research.

[16]  D. Mock,et al.  Marginal maternal biotin deficiency in CD-1 mice reduces fetal mass of biotin-dependent carboxylases. , 2005, The Journal of nutrition.

[17]  Y. Cha,et al.  Pregnancy increases urinary loss of carnitine and reduces plasma carnitine in Korean women. , 2005, The British journal of nutrition.

[18]  I. Bykov,et al.  Acylcarnitine profile in tissues and body fluids of biotin-deficient rats with and withoutl-carnitine supplementation , 1994, Journal of Inherited Metabolic Disease.

[19]  D. Mock,et al.  Biochemical and Molecular Actions of Nutrients Marginal Biotin Deficiency Is Teratogenic in ICR Mice , 2003 .

[20]  S. Krähenbühl,et al.  Myocardial function and energy metabolism in carnitine-deficient rats , 2003, Cellular and Molecular Life Sciences CMLS.

[21]  W. März,et al.  Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate Published, JLR Papers in Press, October 16, 2002. DOI 10.1194/jlr.M200200-JLR200 , 2003, Journal of Lipid Research.

[22]  A. Evans,et al.  Pharmacokinetics of L-Carnitine , 2003, Clinical pharmacokinetics.

[23]  D. Mock,et al.  Indicators of marginal biotin deficiency and repletion in humans: validation of 3-hydroxyisovaleric acid excretion and a leucine challenge. , 2002, The American journal of clinical nutrition.

[24]  R. S. Solórzano-Vargas,et al.  Holocarboxylase synthetase is an obligate participant in biotin-mediated regulation of its own expression and of biotin-dependent carboxylases mRNA levels in human cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Krähenbühl,et al.  Development and characterization of an animal model of carnitine deficiency. , 2001, European journal of biochemistry.

[26]  J. Zempleni,et al.  Marginal biotin deficiency is teratogenic. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[27]  H. Said Biotin bioavailability and estimated average requirement: why bother? , 1999, The American journal of clinical nutrition.

[28]  D. Mock,et al.  Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased biotin status in experimental biotin deficiency. , 1997, The American journal of clinical nutrition.

[29]  D. Mock Determinations of biotin in biological fluids. , 1997, Methods in enzymology.

[30]  J. Takala,et al.  Moderate Carnitine Depletion and Long-Chain Fatty Acid Oxidation, Exercise Capacity, and Nitrogen Balance in the Rat , 1994, Pediatric Research.

[31]  C. Rebouche Carnitine function and requirements during the life cycle , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  D. Stumpf,et al.  Propionate mitochondrial toxicity in liver and skeletal muscle: acyl CoA levels. , 1991, Biochemical medicine and metabolic biology.

[33]  G. Cederblad,et al.  Plasma carnitine and renal-carnitine clearance during pregnancy. , 1986, The American journal of clinical nutrition.

[34]  R. Chalmers,et al.  Urinary Excretion of l-Carnitine and Acylcarnitines by Patients with Disorders of Organic Acid Metabolism: Evidence for Secondary Insufficiency of l-Carnitine , 1984, Pediatric Research.

[35]  C. Rebouche,et al.  Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport. , 1984, The Journal of clinical investigation.